Understanding the human body is a team effort. That's where the Yachtel group comes in.

Researchers at Yachtolt have been delving into the secrets of probiotics for 90 years.

Yacold also partners with nature portfolio to advance gut microbiome science through the global grants for gut health, an investigator-led research program.

To learn more about Yachtolt, visit yawcult.co.

.jp. That's Y-A-K-U-L-T.C-O.J-P. When it comes to a guide for your gut, count on Yacult.

This is Scientific Americans' 60-second science. I'm Steve Merski.

I guess we're sort of in the middle of a major virology education.

Charles Rice of the Rockefeller University in New York City.

I think that, you know, the field has definitely changed, you know, since the days when I was a graduate student. And I think

one of the things that is very reassuring now is really the global response to this pandemic

in the sort of academic and clinical and, you know, sort of pharma communities,

the rate of progress. Earlier today, October 5th, 2020, Rice was informed that he had won the

Nobel Prize in physiology or medicine for the discovery of the virus that causes hepatitis C.

The identification of the virus has led to tests and treatments for the condition.

Rice shared the prize with Harvey Alter of the National Institutes of Health and Michael Houghton of the University of Alberta.

It took us months and months of toil to sequence a single viral genome.

Now people can do that in a matter of hours. And the rate at which people

have been able to sort of make progress on understanding SARS-CoB-2 and COVID-19 is just spectacular.

Rice spoke this morning on a web press conference from Rockefeller University. So I think it's taught us a lot of things about science in general. If there's really a

pressing problem, we sort of, you know, mobilize people all around the world to sort of work on

these problems. Really, you know, great progress can be made. You know, people would love to have a cure in a week or a vaccine in a week.

I mean, that's not feasible.

...